Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
SAN ANTONIO, Texas, Feb. 23, 2016 -- In a new analysis by Verify Markets, the Asia Pacific healthcare 3D printing market was estimated to be over $35.0 million in 2015. The market is primarily driven by rise in demand for customized prosthetics, as well as the emergence of Asia Pacific as a medical tourism hub. China was the largest market in 2015, making up more than 35 percent of the total market in revenue.
The Asia Pacific healthcare 3D printing market is expected to experience a double-digit growth rate during the forecast period (2016-2022). Increasing competition and government support for smart manufacturing is expected to elevate the Chinese market. Increasing demand for customized prosthetics and higher spending power among patients are expected to drive growth in the Australian healthcare 3D printing market. South Korea, Singapore and Malaysia are emerging as medical tourism destinations. The use of biological material to print human organs in the future will likely revolutionize the industry.
3D printing services are preferred over direct purchase of 3D printers due to the high initial costs associated with upfront printer purchase. The use of 3D printers in various healthcare applications (such as dental, surgery and prototyping, among others) is expected to rise during the forecast period. The Asia Pacific 3D printing market is still emerging and is highly competitive with the presence of both local and international participants.
The key companies in this market include Stratasys, Ltd., Materialise NV, 3D Printing Systems Corporation, Tiertime, Shaanxi Hengtong Intelligent Machine Co., Ltd., Wuhan Binhu Mechanical & Electrical Co., Ltd., Made for ME, Carmina, Rokit, Moment, Imaginarium, J Group Robotics and Brahma3, among others.
The countries covered in this research include China, India, Malaysia, Singapore, Taiwan, South Korea, and Australia. The report is highly detailed and provides key market drivers, restraints, revenue forecasts by technology, service and materials, market share analysis, and key market trends by each country. The base year for the study in 2015 and revenue forecasts are provided until 2022. For additional information, please review our report titled ‘Asia Pacific Healthcare 3D Printing Market’. For more reports on the Healthcare IT market, please visit our website or email us at [email protected]. Follow us for more updates on Twitter @verify_markets and LinkedIn: https://www.linkedin.com/company/verify-markets.
Contact: Haley Rico Phone: 210-595-9687 Email: [email protected]
